Therapeutic use of a growth factor, NsG33

Details for Australian Patent Application No. 2005229434 (hide)

Owner NsGene A/S

Inventors Gronborg, Mette; Blom, Nikolaj; Kusk, Philip; Petersen, Thomas Nordahl; Brunak, Soren; Wahlberg, Lars; Johansen, Teit E.

Agent Cullens

Pub. Number AU-B-2005229434

PCT Pub. Number WO2005/095450

Priority 60/575,086 28.05.04 US; PA 2004 00510 30.03.04 DK; PA 2004 00843 28.05.04 DK

Filing date 30 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 30 September 2010

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/095450 Priority application(s): WO2005/095450

30 September 2010 Application Accepted

  Published as AU-B-2005229434

27 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229435-Methods for the preparation of (3R,3aS,6aR) hexahydrofuro[2,3-b]furan-3-ol

2005229417-Plan nutrient based on o,p-ethylene(bis)hydroxyphenyl glycines